Clinical Trial Update: Study of ASTX029 in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Taiho Oncology conducted a Phase 1/2 study of ASTX029 in adults with advanced solid tumors. The trial is completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• ASTX029

Snippet

Sponsor: Taiho Oncology, Inc. | Conditions: Solid Tumor, Adult | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-07-03